101 related articles for article (PubMed ID: 14571807)
1. A case of hepatocellular carcinoma (HCC): treatment with local application of alcohol and interleukin 2 (IL-2).
Krastev Z; Koltchakov V; Popov D; Alexiev A; Koten JW; Den Otter W
Hepatogastroenterology; 2003; 50(53):1647-9. PubMed ID: 14571807
[TBL] [Abstract][Full Text] [Related]
2. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
Vallone P; Catalano O; Izzo F; Siani A
Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral echo-guided injection of interleukin-2 and lymphokine-activated killer cells in hepatocellular carcinoma.
Gandolfi L; Solmi L; Pizza GC; Bertoni F; Muratori R; De Vinci C; Bacchini P; Morelli MC; Corrado G
Hepatogastroenterology; 1989 Oct; 36(5):352-6. PubMed ID: 2559885
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
[TBL] [Abstract][Full Text] [Related]
5. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
Wong LL; Tanaka K; Lau L; Komura S
Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
[TBL] [Abstract][Full Text] [Related]
6. Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablation.
Shiina S; Tateishi R; Yoshida H; Kanai F; Omata M
Saudi Med J; 2007 Jun; 28(6):831-7. PubMed ID: 17530094
[TBL] [Abstract][Full Text] [Related]
7. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
[TBL] [Abstract][Full Text] [Related]
8. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F
Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
[TBL] [Abstract][Full Text] [Related]
9. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
[TBL] [Abstract][Full Text] [Related]
10. The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.
Ichida T; Van Thiel DH; Hassanein T
Hepatogastroenterology; 1996; 43(12):1575-83. PubMed ID: 8975968
[TBL] [Abstract][Full Text] [Related]
11. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
12. [Massive hepatic necrosis secondary to treatment of hepatocellular carcinoma by percutaneous alcoholization].
Boucher E; Carsin A; Raoul JL; Marchetti C; Joram F; Kerbrat P
Gastroenterol Clin Biol; 1998 Apr; 22(4):459-61. PubMed ID: 9762276
[TBL] [Abstract][Full Text] [Related]
13. [A case of adrenal metastasis of hepatocellular carcinoma effectively treated with local ethanol injection].
Kunieda K; Seki Y; Kubota Y; Kano T; Kawashima S; Mizuno T; Sameshima Y; Kunieda Y
Rinsho Hoshasen; 1989 Nov; 34(12):1525-8. PubMed ID: 2556595
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Ethanol Injection in the treatment of hepatocellular carcinoma in cirrhosis.
Livraghi T
Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1248-53. PubMed ID: 9730383
[No Abstract] [Full Text] [Related]
15. Local injection therapy for hepatocellular carcinoma.
Lin XD; Lin LW
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):16-21. PubMed ID: 16481276
[TBL] [Abstract][Full Text] [Related]
16. Technologies for ablation of hepatocellular carcinoma.
Callstrom MR; Charboneau JW
Gastroenterology; 2008 Jun; 134(7):1831-5. PubMed ID: 18486619
[No Abstract] [Full Text] [Related]
17. Surgery or ablation for hepatocellular carcinoma.
Hung BP
Ann Surg; 2009 Feb; 249(2):350. PubMed ID: 19212196
[No Abstract] [Full Text] [Related]
18. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous ethanol and lipiodol injection therapy for hepatocellular carcinoma.
Kurokohchi K; Masaki T; Miyauchi Y; Funaki T; Yoneyama H; Miyoshi H; Yoshida S; Himoto T; Morishita A; Uchida N; Watanabe S; Kuriyama S
Int J Oncol; 2004 Feb; 24(2):381-7. PubMed ID: 14719115
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.
Nouso K; Matsumoto E; Kobayashi Y; Nakamura S; Tanaka H; Osawa T; Ikeda H; Araki Y; Sakaguchi K; Shiratori Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):453-8. PubMed ID: 17725599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
